Federal grants to Sinopia Biosciences Inc
Sinopia Biosciences Inc in San Diego, California received $9.3 million in federal grants from fiscal 2021 to 2025, across 7 awards. Its largest program was Extramural Research Programs in the Neurosciences and Neurological Disorders, with $3.4 million. In fiscal 2025 it was awarded $1.5 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$9.3 million
- Awards7
- Awarded in FY 2025$1.5 million
- Largest award$3.4 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $1.9 million |
| FY 2022 | 2 | $1.2 million |
| FY 2023 | 1 | $1.6 million |
| FY 2024 | 3 | $3.1 million |
| FY 2025 | 3 | $1.5 million |
Programs that fund Sinopia Biosciences Inc
| Program | Awards | Amount |
|---|---|---|
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 1 | $3.4 million |
| Biomedical Research and Research Training | 3 | $2.9 million |
| Oral Diseases and Disorders Research | 2 | $2.7 million |
| Cancer Biology Research | 1 | $285,599 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 7 | $9.3 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Preclinical development of a novel therapeutic for parkinson's disease - project summary parkinson’s disease (PD) is the second most common neurodegenerative disorder, afflicting ~1 million americans. Levodopa is the gold-standard symptomatic treatment for pd by elevating dopamine levels in the brai | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 17, 2021 | $3.4 million |
| Preclinical assessment of a novel compound for treating radiation-induced oral mucositis - project summary inflammation and ulceration of mucosal tissue, called mucositis, is a severe side effect of many common treatments in oncology, including chemo- and radiotherapy. Mucositis development is costl | Oral Diseases and Disorders Research | September 4, 2024 | $2.4 million |
| Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery - project summary high-throughput omics technologies allow for measuring various biomolecules comprehensively and over the past decade have become exponentially less expensive. | Biomedical Research and Research Training | February 5, 2021 | $2.2 million |
| Development of neural network models to enable efficient metabolomic characterization of compound libraries for data-driven drug discovery - project summary data-driven drug discovery (D4) combines phenotypic-based drug discovery with high-throughput omics technologies and machine learning. Like phe | Biomedical Research and Research Training | July 23, 2025 | $350,000 |
| Development and validation of data standards and computational methods for large scale metabolomics data analysis for data driven drug discovery - project summary data-driven drug discovery (D4) is the combined utilization of the phenotypic-based drug discovery paradigm with high-throughput omics te | Biomedical Research and Research Training | April 18, 2024 | $343,261 |
| Preclinical assessment of a novel compound for treating radiation-induced oral mucositis - project summary inflammation and ulceration of mucosal tissue, called mucositis, is a severe side effect of many common treatments in oncology, including chemo- and radiotherapy. Mucositis development is costl | Oral Diseases and Disorders Research | September 20, 2022 | $318,284 |
| Development of a metabolomics enabled ai/ml platform for discovery of new treatments to enhance drug sensitivity in cancer - project summary coupling high-throughput omics technologies with machine learning and the phenotypic-based drug discovery paradigm allows for data-driven drug discovery (D4). | Cancer Biology Research | September 18, 2025 | $285,599 |
Questions people ask
How much federal grant money does Sinopia Biosciences Inc get?
$9.3 million in 7 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Sinopia Biosciences Inc the most?
The Department of Health and Human Services, with $9.3 million in 7 awards.
What is Sinopia Biosciences Inc's largest federal grant?
$3.4 million under Extramural Research Programs in the Neurosciences and Neurological Disorders, with its first action in the period on September 17, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Sinopia Biosciences Inc?
Its largest are Extramural Research Programs in the Neurosciences and Neurological Disorders, Biomedical Research and Research Training and Oral Diseases and Disorders Research.
Other grant recipients in San Diego
- San Diego Association of Governments
- Metropolitan Transit System
- General Atomics
- Neighborhood House Association
- San Diego County Regional Airport Authority
- San Diego State University Foundation
- San Diego Unified School District
- Family Health Centers of San Diego Inc
Largest federal grant recipients in California · Federal grants in California